论文部分内容阅读
目的研究低分子肝素钠治疗急性缺血性中风的疗效。方法用低分子肝素钠治疗30例急性缺血性脑卒中与常规用0.9%生理盐水250毫升+舒血宁20毫升治疗32例急性缺血性脑卒中进行比较,两组间年龄、性别及治疗前神经功能缺损程度无明显差异(P>0.05),具有可比性。治疗组30例用低分子肝素钠4000AxaIU,Bid×10天,对照组32例用0.9%生理盐水250毫升+舒血宁20毫升,QD×10天。开始用药时间均在起病48小时内。结果低分子肝素钠治疗组的神经功能改善明显优于对照组(P<0.01),未见出血等不良反应。结论低分子肝素钠治疗急性缺血性脑卒中疗效较好,出血副作用小。
Objective To study the therapeutic effect of low molecular weight heparin on acute ischemic stroke. Methods A total of 30 patients with acute ischemic stroke treated with low molecular weight heparin sodium and 32 patients treated with 0.9% normal saline 250 mL and Shuxuening 20 mL were used to treat 32 patients with acute ischemic stroke. The age, sex and treatment No significant difference in the degree of anterior denervation (P> 0.05), comparable. 30 cases of treatment group with low molecular weight heparin 4000AxaIU, Bid × 10 days, 32 cases of control group with 0.9% saline 250 ml + Shuxuening 20 ml, QD × 10 days. Start medication time are within 48 hours of onset. Results The improvement of neurological function in low molecular weight heparin treatment group was significantly better than that in control group (P <0.01). No adverse reaction such as bleeding was found. Conclusion Low molecular weight heparin is effective in the treatment of acute ischemic stroke with little side effects of bleeding.